Inflammation and Gastrointestinal Cancers

Volume 185 of the series Recent Results in Cancer Research pp 159-171


Targeted Drug Therapies and Cancer

  • K. L. YimAffiliated withThe Royal Marsden NHS Foundation Trust Email author 
  • , D. CunninghamAffiliated withThe Royal Marsden NHS Foundation Trust

* Final gross prices may vary according to local VAT.

Get Access


With the progress of research in molecular biology and greater understanding of cell signalling systems emerge an increasing array of potential targets for the therapy of cancer. While traditional chemotherapy aims to elicit tumour cell death, it also produces undesirable side effects on physiologically proliferating cells. By isolating cell surface receptors which link specific intracellular secondary messenger pathways, researchers are increasingly able to define the biological network which drives cellular function. Of importance are routes involved in malignant transformation, proliferation, survival and angiogenesis. Thus targeted therapy is directed to specific differential growth processes particular to malignant tumours. The principle mode of action generally involves the “lock-and-key” mechanism and identifying the “Achilles’ heel” for drug action. Various targeted agents have been studied and many have translated into significant clinical benefit. This chapter will describe some examples which illustrate the role of this approach in gastrointestinal cancers.